Trials
Search / Trial NCT06437782

Exploration of Health Literacy in Diabetes in Reunion Island and France

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · May 29, 2024

Trial Information

Current as of February 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with type 1, 2 or gestational diabetes taken care in hospital
  • Exclusion Criteria:
  • Patient unable to understand and respect study procedures
  • Patient with cognitive disorder
  • Patient with serious acute complication due to diabetes within 15 days before inclusion
  • Stroke history with neurologic consequences
  • Other specific types of diabetes : chronic calcific pancreatitis, iatrogenic, other secondary diabetes, rare monogenic or genetic diabetes due to insulin resistance

About Centre Hospitalier Universitaire De La Réunion

The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.

Locations

Saint Denis, , Réunion

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0